Free tool
Stocks near their 52-week high
We cover 111 companies trading within 5% of their own 52-week high. The median market value in the group is $13.71B. Across the group, the median move over the past trading day is 0.00%. 100% of the 107 with a 200-day average trade above it. Price change over the past year runs from +7.8% to +133.2% across the middle 80 percent of the group, with a median of +47.9%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
111 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| V | Visa Inc. | $716.76B | Mega cap | +10.25% |
| MA | Mastercard Incorporated | $525.05B | Mega cap | +1.78% |
| MRCK34.SA | Merck & Co., Inc. | $388.60B | Mega cap | +81.07% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| AMGN34.SA | Amgen Inc. | $239.09B | Mega cap | +47.79% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| BILB34.SA | Banco Bilbao Vizcaya Argentaria, S.A. | $162.07B | Large cap | +60.28% |
| PFIZ34.SA | Pfizer Inc. | $161.53B | Large cap | +11.58% |
| N1EM34.SA | Newmont Corporation | $143.08B | Large cap | +73.35% |
| NEM | Newmont Corporation | $138.67B | Large cap | +83.73% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| FCXO34.SA | Freeport-McMoRan Inc. | $113.71B | Large cap | +72.74% |
| FCX | Freeport-McMoRan Inc. | $113.45B | Large cap | +81.57% |
| PSX | Phillips 66 | $96.65B | Large cap | +87.07% |
| CSXC34.SA | CSX Corporation | $95.44B | Large cap | +53.14% |
| CPRL34.SA | Canadian Pacific Kansas City Limited | $83.93B | Large cap | +18.83% |
| DB | Deutsche Bank Aktiengesellschaft | $75.59B | Large cap | +14.81% |
| WPM.TO | Wheaton Precious Metals Corp. | $70.79B | Large cap | +63.18% |
| P1AC34.SA | PACCAR Inc | $68.80B | Large cap | +26.80% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| A1RG34.SA | argenx SE | $63.16B | Large cap | +36.97% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.22B | Large cap | +18.03% |
| NDAQ | Nasdaq, Inc. | $55.60B | Large cap | +5.83% |
| BCE-PS.TO | BCE Inc. | $55.06B | Large cap | +20.07% |
| EA | Electronic Arts Inc | $52.93B | Large cap | +21.84% |
| FNV.TO | Franco-Nevada Corporation | $52.32B | Large cap | +45.52% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| C2CA34.SA | Coca-Cola FEMSA, S.A.B. de C.V. | $47.99B | Large cap | +24.82% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $44.24B | Large cap | +94.70% |
| L1YV34.SA | Live Nation Entertainment, Inc. | $43.67B | Large cap | +7.24% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| EXGR34.SA | Expedia Group, Inc. | $41.96B | Large cap | +65.24% |
| POW-PE.TO | Power Corporation of Canada | $39.80B | Large cap | +72.25% |
| H1BA34.SA | Huntington Bancshares Incorporated | $36.53B | Large cap | +6.30% |
| I1LM34.SA | Illumina, Inc. | $34.10B | Large cap | +113.13% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| BIIB34.SA | Biogen Inc. | $32.56B | Large cap | +47.86% |
| T1EC34.SA | TechnipFMC plc | $29.71B | Large cap | +104.98% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| J1BH34.SA | J.B. Hunt Transport Services, Inc. | $27.06B | Large cap | +83.75% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| SN | SharkNinja, Inc. | $26.56B | Large cap | +56.75% |
| R1FC34.SA | Regions Financial Corporation | $26.32B | Large cap | +17.96% |
| I1NC34.SA | Incyte Corporation | $25.83B | Large cap | +41.91% |
| QSP-UN.TO | Restaurant Brands International Limited Partnership | $25.63B | Large cap | +25.93% |
| G1PI34.SA | Global Payments Inc. | $24.74B | Large cap | +1.36% |
| L1OE34.SA | Loews Corporation | $23.67B | Large cap | +19.65% |
| R1KU34.SA | Roku, Inc. | $23.55B | Large cap | +55.23% |
| KSPI | Joint Stock Company Kaspi.kz | $20.46B | Large cap | +18.99% |
| NDSN | Nordson Corporation | $18.64B | Large cap | +49.78% |
| S1YM34.SA | Gen Digital Inc. | $17.53B | Large cap | −3.91% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| SJM | The J. M. Smucker Company | $13.99B | Large cap | +27.78% |
| H1AS34.SA | Hasbro, Inc. | $13.71B | Large cap | +15.06% |
| SEIC | SEI Investments Company | $13.30B | Large cap | +23.14% |
| CGG.TO | China Gold International Resources Corp. Ltd. | $12.97B | Large cap | +159.57% |
| CHYM | Chime Financial, Inc. | $12.55B | Large cap | +26.43% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +4.97% |
| S1JM34.SA | The J. M. Smucker Company | $12.46B | Large cap | +14.36% |
| MANH | Manhattan Associates, Inc. | $12.42B | Large cap | −2.65% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| T1CH34.SA | Bio-Techne Corporation | $11.51B | Large cap | +23.42% |
| PAYC | Paycom Software, Inc. | $10.47B | Large cap | +2.73% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| P1YC34.SA | Paycom Software, Inc. | $10.38B | Large cap | −3.54% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| F1LS34.SA | Flowserve Corporation | $10.20B | Large cap | +50.74% |
| Z1IO34.SA | Zions Bancorporation, National Association | $9.87B | Mid cap | +16.78% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| M1TC34.SA | Match Group, Inc. | $9.57B | Mid cap | +7.86% |
| D2AR34.SA | Darling Ingredients Inc. | $9.54B | Mid cap | +31.84% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% |
| TXG | 10x Genomics, Inc. | $8.37B | Mid cap | +358.35% |
| SSRM | SSR Mining Inc. | $7.90B | Mid cap | +106.56% |
| SSRM.TO | SSR Mining Inc. | $7.90B | Mid cap | +107.99% |
| N1OV34.SA | NOV Inc. | $7.59B | Mid cap | +72.27% |
| DSV.TO | Discovery Mining Ltd. | $7.44B | Mid cap | +210.02% |
| BPO-PP.TO | Brookfield Office Properties Inc. | $7.13B | Mid cap | +43.15% |
| TMHC | Taylor Morrison Home Corp | $6.67B | Mid cap | +7.62% |
| ANF | Abercrombie & Fitch Co. | $6.56B | Mid cap | +54.94% |
| PAGP | Plains GP Holdings, L.P. | $6.55B | Mid cap | +57.00% |
| PRU.TO | Perseus Mining Limited | $6.29B | Mid cap | +95.20% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +143.24% |
| NIQ | NIQ Global Intelligence plc | $5.53B | Mid cap | +12.22% |
| HAE | Haemonetics Corporation | $4.85B | Mid cap | +93.71% |
| CG.TO | Centerra Gold Inc. | $4.70B | Mid cap | +208.31% |
| A2RE34.SA | Ares Management Corporation | $4.62B | Mid cap | — |
| N2TN34.SA | Nutanix, Inc. | $4.52B | Mid cap | +70.04% |
| R1HI34.SA | Robert Half Inc. | $4.52B | Mid cap | +19.32% |
| HTFL | Heartflow, Inc. | $4.26B | Mid cap | +40.79% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.84% |
| BPO-PY.TO | Brookfield Office Properties Inc. | $4.09B | Mid cap | +22.71% |
| IDYA | IDEAYA Biosciences, Inc. | $4.01B | Mid cap | +66.32% |
| ABCL | AbCellera Biologics Inc. | $3.97B | Mid cap | +181.38% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +55.97% |
| LIFE | Ethos Technologies Inc. | $3.75B | Mid cap | +132.11% |
| OGN | Organon & Co. | $3.62B | Mid cap | +50.67% |
| AAMI | Acadian Asset Management Inc. | $3.39B | Mid cap | +89.34% |
| ATKR | Atkore Inc. | $3.16B | Mid cap | +59.26% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +73.50% |
| MAN | ManpowerGroup Inc. | $2.89B | Mid cap | +52.25% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +61.71% |
| CDNA | CareDx, Inc. | $2.64B | Mid cap | +283.45% |
| RAPP | Rapport Therapeutics, Inc. | $2.52B | Mid cap | +250.70% |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% |
| IOSP | Innospec Inc. | $2.36B | Mid cap | +11.67% |
| PURR | Hyperliquid Strategies Inc. | $2.32B | Mid cap | +196.41% |
| ZYME | Zymeworks Inc. | $2.10B | Mid cap | +96.28% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.